This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37870564
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en mayu de 2011 vědecký článek scientific article published on 04 May 2011 مقالة علمية نشرت في 04 مايو 2011 article scientifique artigo científico bilimsel makale vetenskaplig artikel articolo scientifico наукова стаття, опублікована в травні 2011 wissenschaftlicher Artikel wetenschappelijk artikel vedecký článok article científic научни чланак videnskabelig artikel
p:P577
wds:Q37870564-4FF28E4E-175C-40C0-A385-89878816E812
wdt:P577
2011-05-04T00:00:00Z
p:P2093
wds:Q37870564-1C1B8361-D985-42BE-BC0C-ECCC9066DC6C wds:Q37870564-4F787928-92BC-4E22-B475-985FAA85F793 wds:Q37870564-815C5826-6909-4279-B4FE-E38C6FC04C72 wds:Q37870564-B0344416-9FD2-4F81-8922-CB38D544AAAF
wdt:P2093
Robert Naeije Carl P Arneson Raymond L Benza Mardi Gomberg-Maitland
rdfs:label
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
skos:prefLabel
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
schema:name
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
p:P50
wds:Q37870564-A1C1FD52-6953-47F3-A04E-A0C882F7A23C
wdt:P50
wd:Q87931178
p:P1476
wds:Q37870564-C62FA3E8-6EF4-4349-9692-C2E3B512D612
wdt:P1476
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
p:P304
wds:Q37870564-5010FC14-DA59-43EC-B69A-5E5AB25038EF
wdt:P304
982-989
p:P31
wds:Q37870564-E79155FA-6E8D-4A56-AC56-B2C471CBE946
wdt:P31
wd:Q13442814
p:P921
wds:Q37870564-ACB3BC4B-6B08-4E61-B7E6-7085D606BE1D wds:Q37870564-1624D680-53C3-46A9-870E-9BCE0E8932FB wds:Q37870564-4CEDA312-3A50-472A-89A5-81B45CA21894
wdt:P921
wd:Q41861 wd:Q269829 wd:Q3495231
p:P698
wds:Q37870564-6DBAE3E8-EC32-4201-A81B-161C02FDE684
wdtn:P698
n10:21531577
wdt:P698
21531577
p:P1433
wds:Q37870564-7CAFCE6F-CCB3-4039-8F45-4689EE2824E0
wdt:P1433
wd:Q2364382
p:P433
wds:Q37870564-F3D60F8A-1CB9-43A8-BCE8-BBB288FA8694
p:P478
wds:Q37870564-3BE4CD7B-8932-4733-9D04-BFB63037C892
wdt:P433
9
wdt:P478
30
p:P356
wds:Q37870564-9AA9F652-BA4E-44EC-8C3E-B74A5E674DB4
wdtn:P356
n12:J.HEALUN.2011.03.011
wdt:P356
10.1016/J.HEALUN.2011.03.011